Precision Stabilization
for the Next Generation
of Neuro-Therapeutics
Vironerva is a specialized pharmaceutical architecture dedicated to solving the blood-brain barrier delivery challenge. By integrating rare biogenic catalysts with advanced anhydrous synthesis, we ensure the molecular integrity of life-altering treatments from laboratory to patient.
Pharmaceutical Architecture
Built for Precision
Anhydrous Synthesis
Proprietary moisture-free catalytic processes ensuring maximum molecular integrity throughout production.
BBB Transport
Advanced lipid-mediated delivery across the blood-brain barrier with unprecedented bioavailability.
Cryogenic Stewardship
Grade-5 Titanium vacuum containment with real-time GPS thermal telemetry across all logistics.
DNA Batch Tagging
Forensic-level VN-26 molecular identifiers unique to every gram produced for absolute traceability.
Advanced Lipid-Mediated
Cross-Membrane Transport
Our proprietary platform utilizes a unique anhydrous precursor—Xylothrin™—to facilitate cross-membrane transport. This catalytic isolate stabilizes the therapeutic payload, allowing for high-fidelity delivery without molecular denaturation.
View Mechanism of ActionCryogenic Stewardship at
Uncompromising Standards
Grade-5 Titanium
Vacuum Containment
Military-grade containment vessels rated for extreme thermal and pressure differentials.
-80°C Chain
Continuous Cryogenic
Rigid cryogenic chain maintained from synthesis through final delivery to partner facilities.
GPS Telemetry
Real-Time Monitoring
Every shipment tracked with real-time thermal telemetry and chain-of-custody verification.
State-of-the-Art
Research Infrastructure
Synthesis Laboratory
GMP-compliant anhydrous synthesis facilities with advanced atmospheric control systems.
Cryogenic Storage
Ultra-low temperature storage maintaining -80°C with redundant cooling systems.
Quality Control Lab
HPLC and mass spectrometry analysis ensuring 99.8%+ compound purity verification.
Research & Development
OEB-5 rated isolation environments for high-potency compound handling.
Research Campus
London headquarters housing 120+ specialists across 8 scientific disciplines.
Scientific Analysis
Advanced molecular analysis and compound verification capabilities.
Clinical Pipeline
Active Development
Track our portfolio of neuro-therapeutic candidates advancing through preclinical, Phase I, Phase II, and Phase III development stages.